Home            Past Issues            About IP            About IAP           Author Information            Subscription            Advertisement              Search  

   
research letter

Indian Pediatr 2019;56: 1052-1053

Clinical and Molecular Investigations of Hand, Foot and Mouth Disease Outbreak in Navi Mumbai, India

 

Dhanya Dharmapalan1, Vinay K Saxena2, Shailesh D Pawar2, Tarique HIH Qureshi2 and
Priyanka Surve
2

1Apollo Hospitals, CBD Belapur, Navi Mumbai and 2ICMR-National Institute of Virology, Mumbai Unit, Haffkine Institute Compound, Parel, Mumbai, Maharashtra, India.

Email: [email protected]

   


An outbreak of Hand, Foot and Mouth Disease (HFMD) was reported in Navi Mumbai in July-October 2018. Of 15 HFMD cases, two had recurrences within a month while three had lesions extending to trunk. Coxsackie virus A6 and A16 were detected from 13 cases (CV-A6 from 10 cases and CV-A16 from 3 cases) indicating co-circulation of these viruses.. The present study highlights an urgent need of HFMD surveillance.

Keywords: Coxsackie virus, Epidemiology, Epidemic.



N
avi Mumbai city witnessed an unprecedented rise in cases of Hand, Foot and Mouth Disease (HFMD) in July-October 2018 with two children reporting recurrences in the same year and lesions extending beyond the characteristic distribution over the body. Clinical characteristics were studied and the virological and molecular laboratory diagnosis was carried out to identify the etiological agents.

All children with clinical suspicion of HFMD upto age 18 years during the study period September- October 2018 were included. Stool specimens along with swabs from the throat and vesicles were collected from these children. The specimens (stool, vesicle fluid and throat swabs) were transported in cold chain to the ICMR-National Institute of Virology, Mumbai Unit, Mumbai for molecular diagnosis and virus isolation.Written consent for specimen collection was obtained from the parents of the children by the hospital authorities. Enterovirus (EV) isolation was performed as per the WHO Laboratory Manual protocol (2004) by inoculating human rhabdomyosarcoma (RD) cells. The cultures briefly were incubated at 36oC and cytopathic effect (CPE) was observed for five days. Once CPE was observed, tissue culture material was harvested for RNA extraction using QIAGEN Mini RNA Extraction Kit according to the manufacturer’s instructions. Clinical specimens were used for RNA extraction for direct detection of enteroviruses. Partial VP1 (RT-snPCR) was performed using primers as shown in Table I.

TABLE I Primers used for EV PCR Amplification and Sequencing
Primers Sequences (5’-3’) Region Nucleotide positions
AN89 CAGCACTGACAGCAGYNGARAYNGG VP1 2602-2627
AN88 TACTGGACCACCTGGNGGNAYRWACAT VP1 2977-2951
224 GCIATGYTIGGIACICAYRT VP3 1977-1996
222 CICCIGGIGGIAYRWACAT VP1 2969-2951
011 GCICCIGAYTGITGICCRAA 2A 3408–3389
240 ATICCICCRCARTCICCIGG 2A 3690-3671

 

A total of 17 (four stool, nine vesicle fluids and four throat swabs) specimens were collected from 15 HFMD cases. Stool and vesicle fluid specimens were collected simultaneously from only 2 cases whereas only one specimen was collected from the remaining cases. Of the 15 HFMD cases aged between nine months and 12 years, 13 (13/15) were confirmed to be caused by EV. EV was isolated by culture from different specimens (4/4 stool, 4/9 vesicle fluids and 1/4 throat swabs). Stool specimens yielded highest virus isolations as compared to swabs from vesicles. In 4 children, EV was detected from clinical samples by RT-PCR alone.

Coxsackievirus A6 (CV-A6) was detected in ten cases while Coxsackievirus A16 (CV-A16) was reported in three cases. No mixed infection due to either CVA6 or CVA16 was observed from any case.

Interestingly, three children identified with CV-A6 had extensive rashes, extending to the trunk. Out of these three cases, two had previous history of HFMD. A 2-year-old female child from China excreted CV-A16 in the stool. She was vaccinated twice against enterovirus-A71 (EV-A71) vaccine in China in 2017. No complications were reported in any case.

HFMD presents as sudden appearance in crops of erythematous papulovesicular rashes with a characteristic distribution over the hands, feet, knees, buttocks and intraoral areas. It is commonly seen in children less than 10 years. It is mostly caused by CV-A16 and EV-A71, but can also be caused by serotypes CV-A 2-8, 10, 12 and 14 [1]. The diagnosis of HFMD in India is usually clinical due to limited availability of molecular testing. The disease is by and large self-limiting and resolves within 7-10 days. However, neurological and/or cardiopulmonary complications such as encephalitis, aseptic meningitis, pulmonary oedema and cardio respiratory failure can occur in about 1% of HFMD patients. EV-A71 infections are more severe than CV-A16 across all ages [2].

Recurrences occurred in two cases which could be due to absence of immunity or due to infection with another enterovirus serotype. Extensive lesions over trunks in HFMD with CV-A6 have been reported in Japan [3]. CV-A16 and CV-A6 have also been identified as major causes of HFMD in Southern and Eastern parts of India [4,5].

EV-A71 vaccines are available in mainland China with >90% protective efficacy against EV-A71-associa-ted HFMD [6]. Cross-protection of EV-A71 vaccine to CV-A16 infections does not occur [7].

A similar HFMD outbreak was reported during May-June 2018 in South Mumbai, which is about 25 km away from Navi Mumbai [8]. The phylogenetic analysis of CV-A6 and CV-A16 viruses isolated from these cases from both outbreaks showed that they are genetically closely related (Data not shown).

Co-circulation of CV-A6 and CV-A16 was observed in the reported HFMD outbreak in Navi Mumbai, highlighting an urgent need of virological surveillance to study recurrences and the changing clinical pattern of the disease.

Acknowledgements: Dr Vijay Yewale, Director of Dr Yewale’s Hospital for Children, Navi Mumbai for supporting the study. Dr Mangai Sinha, Dr Vikram Patra, Dr Shruti Kalkekar, Dr Manohar K, Dr Santosh Kangule for referring their patients for this study. Dr DT Mourya, Director, NIV, Pune for his interest in the work and support.

Contributors: DD,VK: conceptualized the study design. DD,VK,SP,TQ,PS: contributed to data collection and analysis. All the authors provided critical inputs into manuscript writing, and approved its final version

Funding: This work was supported by intramural grant from ICMR.

Competing interest: None stated.

References

1. Dharmapalan D. Non Polio enteroviruses. In: Kundu R, Shastri D, chief editors. FAQs in Pediatric Infectious Diseases. 1st Ed. New Delhi: Jaypee Brothers; 2014. p.94-7.

2. Xing W, Liao Q, Viboud C, Zhang J, Sun J, Wu JT, et al. Hand, foot, and mouth disease in China, 2008-12: An epidemiological study. Lancet Infect Dis. 2014;14:308-18.

3. Kobayashi M, Makino T, Hanaoka N,  Shimizu H, Enomoto M, Okabe N, et al. Clinical manifestations of coxsackievirus A6 infection associated with a major outbreak of hand, foot, and mouth disease in Japan. Jpn J Infect Dis. 2013;66:260-1.

4. Vijayaraghavan PM, Chandy S, Selvaraj K, Pulimood S, Abraham AM. Virological investigation of hand, foot, and mouth disease in a tertiary care center in South India. J Glob Infect Dis. 2012;4:153-61.

5. Gopalkrishna V1, Patil PR, Patil GP, Chitambar SD. Circulation of multiple enterovirus serotypes causing hand, foot and mouth disease in India. J Med Microbiol. 2012;61:420-5.

6. Chong P, Liu CC, Chow YH, Chou AH, Klein M. Review of enterovirus 71 vaccines. Clin Infect Dis. 2015;60:797-803.

7. Aswathyraj S, Arunkumar G, Alidjinou EK. Hand, foot and mouth disease (HFMD): emerging epidemiology and the need for a vaccine strategy. 2016;205:397.

8. Rising Cases of foot, hand and mouth infection in South Mumbai.Mumbai Mirror. 2018 May 8; Mumbai. Available from: https://mumbaimirror.indiatimes.com / mumbai/ cover-story/rising-cases-of-foot-hand-and-mouth-infection-in-south-mumbai/articleshow/64071077.cms. Accessed November 28, 2018.


 

Copyright © 1999-2019 Indian Pediatrics